<qa>  What is the overall response rate in patients with previously untreated CD20-positive bulky stage- Determine the overall and complete response rate in patients with previously untreated CD20-positive bulky stage II or stage III or IV follicular non-Hodgkins lymphoma treated with rituximab and galiximab. 